| Introduction | H1N1 is a subtype specie of Influenza A virus. H1N1 Influenza Virus has mutated into various strains such as the Spanish Flustrain, mild humanflu strains, endemic pigstrains, and various strains found in birds. The Influenza A Virus is a globular particle |
| De | Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/ New Caledonia/20/99 IVR 116. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. |
| Inactivation | Thimerosal and beta propiolactone treatment This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work. |
| Physical Appearance | Sterile Filtered colorless solution FormulationThe H1N1 A/New Caledonia/20/99 IVR solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal. |
| Stability | A/New Caledonia/20/99 IVR although stable 4°C for 4 weeks, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles. |
| Immunological Activity | Tested with anti-influenza A monoclonal antibodies in ELISA.Serological studies of influenza A virus, immunogen for antibody production. |
| Purity | Greater than 90.0% as determined byAnalysis by SDS-PAGE. |
| Usage | ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals. |
